Tabira Yoichi, Sakaguchi Tomonori, Yoshida Yasushi, Kuhara Hiroshi, Kawasuji Michio
Department of Gastroenterological Surgery, Faculty of Medical and Pharmaceutical Sciences, Kumamoto University, Japan.
Hepatogastroenterology. 2006 Sep-Oct;53(71):715-9.
BACKGROUND/AIMS: Prognosis of esophageal carcinoma with multiple metastatic lymph nodes is dismal despite radical operation and adjuvant therapy. We investigated prognostic factors for curatively resected esophageal carcinoma with multiple positive nodes.
From January 1983 to December 2002, 343 patients with thoracic esophageal carcinoma underwent an esophagectomy with curative intent. Of these patients, 82 patients were associated with 4 or more histopathologically positive nodes. Of these patients, 59 patients underwent a curative resection. Of these 59 patients, 7 patients who died of postoperative complications during the hospital stay were excluded. Therefore, 52 patients were enrolled in this study. Survival curves were compared after stratifications according to 14 clinicopathologic variables. Independent prognostic factors were detected using a multivariate Cox proportional hazard model.
The cumulative 5-year survival rate for the subjects was 10.6%. The factors affecting cumulative survival rate by a univariate analysis were intramural metastasis (absence vs. presence) (p=0.03), and postoperative therapy (performed vs. not performed) (p=0.02). A multivariate analysis detected the performance of postoperative therapy (Hazard Ratio= 0.390, p= 0.002) and the absence of intramural metastasis (Hazard ratio=0.429, p=0.01) as positive prognostic factors.
The positive prognostic factors for esophageal carcinoma with multiple lymph node metastases were the absence of intramural metastasis and the performance of adjuvant therapy.
背景/目的:尽管进行了根治性手术和辅助治疗,但伴有多个转移淋巴结的食管癌预后仍很差。我们研究了根治性切除的伴有多个阳性淋巴结的食管癌的预后因素。
1983年1月至2002年12月,343例胸段食管癌患者接受了根治性食管切除术。其中,82例患者有4个或更多组织病理学阳性淋巴结。这些患者中,59例接受了根治性切除。在这59例患者中,7例在住院期间死于术后并发症被排除。因此,本研究纳入52例患者。根据14个临床病理变量分层后比较生存曲线。使用多变量Cox比例风险模型检测独立预后因素。
受试者的累积5年生存率为10.6%。单变量分析影响累积生存率的因素为壁内转移(无vs.有)(p=0.03)和术后治疗(进行vs.未进行)(p=0.02)。多变量分析检测到术后治疗(风险比=0.390,p=0.002)和无壁内转移(风险比=0.429,p=0.01)作为阳性预后因素。
伴有多个淋巴结转移的食管癌的阳性预后因素为无壁内转移和进行辅助治疗。